Back to News
Market Impact: 0.55

RKLB Stock To $85?

RKLBSPYUNH
Company FundamentalsAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookTechnology & InnovationMarket Technicals & FlowsInfrastructure & DefenseAntitrust & Competition

Rocket Lab (RKLB) has experienced a nearly 90% year-to-date stock surge in 2025, driven by successful launches and new contracts for its Neutron rocket program. Analysts project significant further upside, targeting over $85 per share by 2027—an 80% increase—contingent on revenue doubling to $1.2 billion, which would normalize its current 50x trailing revenue multiple. While growth is supported by Electron scaling, Neutron commercialization, and space systems integration, and catalysts include government contracts and commercial satellite demand, investors must weigh substantial execution risks, competitive pressures, high capital requirements, and the company's current loss-making status against potential gains.

Analysis

Rocket Lab (RKLB) has demonstrated significant market momentum, with its stock appreciating nearly 90% year-to-date in 2025, driven by successful launches and strategic contract wins for its next-generation Neutron rocket. The company's growth narrative is underpinned by a projection to more than double last-twelve-month revenues of $504 million to approximately $1.2 billion by 2027. This expansion is expected to be fueled by scaling its established Electron launch services, commercializing the Neutron rocket to access the more lucrative large-payload market, and growing its higher-margin space systems and satellite manufacturing business. Despite this top-line potential, the company remains unprofitable, reporting a net loss of $231 million, equivalent to a -46% net income margin over the last year. The stock's valuation is steep, trading at nearly 50 times trailing revenues, reflecting a high-growth premium. The analyst case for an $85 share price—an approximate 80% upside—is contingent not just on achieving the $1.2 billion revenue target but also on sustaining a rich valuation multiple of 35x projected 2027 sales. This optimistic outlook is balanced by substantial risks, including execution risk on the Neutron program, intense competition from incumbents like SpaceX, high capital requirements for expansion, and the stock's historical volatility, evidenced by an 83% value loss during 2022.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.